BUZZ-Aeterna Zentaris Inc: Licenses drug to China-based company

Mon Dec 1, 2014 10:01am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian company's U.S.-listed shares up 13.5 pct at 60 cents in early trading

** Toronto-listed shares up 9.8 pct at 67 Canadian cents

** Company licenses lead anti-cancer compound zoptarelin doxorubicin to China-based Sinopharm A-Think Pharmaceuticals Co Ltd for $1 mln

** Aeterna Zentaris licenses rights to develop the drug in China, Hong Kong and Macao

** Up to Friday's close, Aeterna's U.S. shares had slumped about 62 pct this year